BISProShares UltraShort NASDAQ Biotechnology
BIS Fund Description
BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.
BIS Factset Analytics Insight
BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.
BIS Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a N/A out of 5.